For Immediate Release: April 12, 2022 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency: On April 8, the FDA cleared Fitbit’s Irregular Rhythm Notifications software intended to be used with …
FDA News Release Agency Committed to Using All Available Tools to Stop Online Businesses Illegally Selling Potentially Harmful Drug Products to Consumers For Immediate Release: April 12, 2022 The U.S. Food and Drug Administration and the U.S. Drug …
For Immediate Release: November 04, 2022 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency: On Thursday, the FDA issued a safety communication warning parents, caregivers, and health care …
For Immediate Release: October 04, 2022 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency: Today, the FDA posted a Constituent Update, highlighting that in September, the FDA and CDC signed a …
For Immediate Release: April 08, 2022 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency: On April 7, the FDA authorized an extension for the shelf life of the refrigerated Janssen COVID-19 …
For Immediate Release: April 08, 2022 Statement From: Robert M. Califf, M.D., MACC Commissioner of Food and Drugs - Food and Drug Administration Ensuring the availability of innovative interventions for people is a shared priority for both the Centers for …
For Immediate Release: April 05, 2022 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency: Today, the FDA announced sotrovimab is no longer authorized to treat COVID-19 in any U.S. region due to …
For Immediate Release: May 04, 2022 The U.S. Food and Drug Administration today permitted marketing for the first in vitro diagnostic test for early detection of amyloid plaques associated with Alzheimer’s disease. The Lumipulse G β-Amyloid Ratio (1-42/1- …
For Immediate Release: May 04, 2022 Today, the U.S. Food and Drug Administration issued warning letters to five companies for selling products labeled as containing delta-8 tetrahydrocannabinol (delta-8 THC) in ways that violate the Federal Food, Drug, and …
For Immediate Release: March 29, 2022 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency: Today, the FDA authorized a manufacturing change for the Moderna COVID-19 Vaccine to include an …
For Immediate Release: March 29, 2022 Today, the U.S. Food and Drug Administration authorized a second booster dose of either the Pfizer-BioNTech or the Moderna COVID-19 vaccines for older people and certain immunocompromised individuals. The FDA …
For Immediate Release: March 28, 2022 The U.S. Food and Drug Administration (FDA) announced today that Bravo Packing, Inc., an animal food manufacturing company of Carney’s Point, New Jersey, has agreed to stop selling, manufacturing and distributing raw …
FDA News Release Fiscal Year 2023 Budget Request Reflects 34% Increase, Focuses on Immediate Priorities For Immediate Release: March 28, 2022 Today, the U.S. Food and Drug Administration announced it is requesting a total budget of $8.4 billion as part of …
For Immediate Release: March 25, 2022 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency: Today, the FDA is issuing a 30-day procedural notice on the preliminary quantitative consumer research it …
For Immediate Release: March 24, 2022 Today, the U.S. Food and Drug Administration took additional actions as part of the agency’s work to ensure any electronic nicotine delivery system (ENDS) products available for sale have demonstrated that marketing of …
For Immediate Release: March 22, 2022 The FDA and representatives from the medical device industry have reached an agreement on proposed recommendations for the fifth reauthorization of the medical device user fee program. Under the new agreement, the FDA …
For Immediate Release: March 22, 2022 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency: On March 22, the FDA published a notice to clarify that the effectiveness of certain provisions of the …
For Immediate Release: March 21, 2022 Today, the U.S. Food and Drug Administration is announcing a virtual meeting of its Vaccines and Related Biological Products Advisory Committee (VRBPAC) on Wed., April 6, to discuss considerations for future COVID-19 …
For Immediate Release: March 18, 2022 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency: On March 18, the FDA added the following frequently asked questions to the COVID-19 Test FAQs: Are at- …
FDA News Release FDA Has Taken Several Steps in Recent Years to Support Increased Availability of Opioid Overdose Reversal Drug For Immediate Release: March 17, 2022 The U.S. Food and Drug Administration will host a virtual public workshop on Mar. 29, to …
03 days 21:43:36
